Filter
2422
Filtered Results: 2422
Text search:
drug-resistance
infections
Featured
Recommendations
275
New Publications
659
Language
Document type
No document type
1415
Guidelines
376
Studies & Reports
354
Manuals
98
Strategic & Response Plan
74
Fact sheets
37
Training Material
35
Situation Updates
14
Infographics
11
Resource Platforms
3
Brochures
2
Online Courses
2
Videos
1
Countries / Regions
India
137
Kenya
72
South Africa
70
Western and Central Europe
67
Global
58
Ethiopia
56
Africa
45
Uganda
44
Eastern Europe
42
Nepal
41
Tanzania
41
Nigeria
37
Zambia
35
Liberia
33
Sierra Leone
30
Malawi
30
Latin America and the Carribbean
28
Rwanda
26
Ghana
24
Namibia
24
Myanmar / Burma
24
Philippines
23
Bangladesh
23
Asia
22
Cambodia
21
South–East Asia Region
21
Zimbabwe
18
Lesotho
17
Ukraine
16
Russia
15
Senegal
14
Indonesia
13
Mozambique
12
Cameroon
11
Congo, Democratic Republic of
11
West and Central Africa
10
Botswana
10
East and Southern Africa
9
Albania
8
Burkina Faso
8
Middle East and North Africa
8
Eswatini/ Swaziland
8
Thailand
7
Pakistan
7
Colombia
6
Syria
6
USA
6
Haiti
6
Venezuela
6
Eastern Europe and Central Asia
6
Argentina
6
Guinea
5
Georgia
5
Tajikistan
4
Benin
4
China
4
Germany
4
Western Pacific Region
4
Brazil
4
Sudan
4
North Macedonia
3
Iran
3
Laos
3
Peru
3
Jordan
3
Lebanon
3
Vietnam
3
Central African Republic
3
Bhutan
3
South Sudan
3
Iraq
3
Somalia
3
Timor Leste/ East Timor
2
Mexico
2
El Salvador
2
Estonia
2
Afghanistan
2
Morocco
2
Armenia
2
Saudi Arabia
2
Paraguay
2
Gabon
2
Uruguay
2
Tunisia
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Moldova
2
Sri Lanka
2
Yemen
2
Mali
2
Madagascar
2
Switzerland
1
Serbia
1
Turkey
1
Gambia
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Guinea-Bissau
1
North America
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Nicaragua
1
Egypt
1
Greece
1
Honduras
1
Angola
1
Libya
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
854
Clinical Guidelines
283
Public Health
104
Women & Child Health
76
Key Resources
48
Capacity Building
34
Pharmacy & Technologies
32
Annual Report MEDBOX
1
Toolboxes
TB
440
HIV
327
AMR
316
NTDs
90
COVID-19
81
Rapid Response
58
Mental Health
55
Pharmacy
54
Caregiver
43
Planetary Health
42
Ebola
32
Refugee
27
Global Health Education
27
NCDs
20
Polio
15
Conflict
13
Cholera
12
Health Financing Toolbox
11
Natural Hazards
7
Disability
7
Zika
4
Specific Hazards
3
Social Ethics
1
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who release...
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug consumers. These coupled with rapid spread of res...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
Antimicrobial agents like antibiotics are essential to treat some human and animal diseases. Microbes, such as bacteria, can develop resistance to antimicrobials meaning that a drug such as an antibiotic is no longer effective in treating the infection. The development of resistance is caused by the...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
This document outlines the concept and content of the WHO people-centred approach to addressing antimicrobial resistance (AMR) in the human health sector. The proposed approach recognizes and aims to address the challenges and health system barriers people face when accessing health services to prev...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
Antimicrobial resistance (AMR) is one of the world’s top 10 public health threats. The World Health Organization (WHO) in the African Region, using the Antimicrobial Stewardship assessment tool, has assessed Member States progress on strengthening national capacity need for effective implementatio...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
